Baricitinib Trial for Job Syndrome Patients with Lupus-Like Disease or Atopic Dermatitis
A clinical trial is evaluating the safety and tolerability of baricitinib in patients with Job syndrome who also have lupus-like disease or atopic dermatitis.
Indication
Clinical and regulatory intelligence for Autoimmune Disease with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.